ong-term Effects of an Angiotensin II Type 1 Receptor Blocker in Hypertensive Patients with Chronic Kidney Disease and Metabolic Syndrome
Phase 4
- Conditions
- Hypertension Chronic kidney disease Metabolic syndrome
- Registration Number
- JPRN-UMIN000010892
- Lead Sponsor
- Department of Cardiology Kinu Medical Association Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
heart failure or left ventricular dysfunction (ejection fraction <45%) history of ischemic heart disease such as angina pectoris or myocardial infarction arteriosclerosis obliterans (ankle-brachial index [ABI] <0.9) intake of antioxidants such as vitamins C and E or thiazolidinediones such as pioglitazone insulin therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method